Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial
Authors:
- Bruce A. LoweBLBruce A. Lowe
- Paul F. SchellhammerPSPaul F. Schellhammer
- Donald L. LammDLDonald L. Lamm
- Sam D. GrahamSGSam D. Graham
- H.BArton GrossmanHGH.BArton Grossman
- William A. SeeWSWilliam A. See
- James O. PeabodyJPJames O. Peabody
- Timothy D. MoonTMTimothy D. Moon
- Robert C. FlaniganRFRobert C. Flanigan
- E.DAvid CrawfordECE.DAvid Crawford
- Joel MorganrothJMJoel Morganroth
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cancer statistics, 1995CA: A Cancer Journal for Clinicians, 1995
- Durability of the Tumor-Free Response for Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, 1994
- Dose-Response of Bacillus Calmette-Guerin in the Treatment of Superficial Bladder CancerJournal of Urology, 1992
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- Biology and Management of Bladder CancerNew England Journal of Medicine, 1990
- Long-Term Results of Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder CancerJournal of Urology, 1989
- A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer.Journal of Clinical Oncology, 1987
- Risks and Benefits of Repeated Courses of Intravesical Bacillus Calmette-guerin Therapy for Superficial Bladder CancerJournal of Urology, 1987
- Non-Invasive Papillary Carcinoma of the Bladder Associated with Carcinoma in SituJournal of Urology, 1976
- Infiltrating Carcinoma of the Bladder: Relation of Depth of Penetration of the Bladder Wall to Incidence of Local Extension and MetastasesJournal of Urology, 1946